RODENT STROKE MODEL GUIDELINES FOR PRECLINICAL STROKE TRIALS (1ST EDITION).
about
Cerebral collateral circulation in experimental ischemic strokeDynamics of neuroinflammation in the macrosphere model of arterio-arterial embolic focal ischemia: an approximation to human stroke patterns.A Comparative Study of Variables Influencing Ischemic Injury in the Longa and Koizumi Methods of Intraluminal Filament Middle Cerebral Artery Occlusion in MiceThe science of cerebral ischemia and the quest for neuroprotection: navigating past failure to future successThreats to validity in the design and conduct of preclinical efficacy studies: a systematic review of guidelines for in vivo animal experimentsThe role for infarct volume as a surrogate measure of functional outcome following ischemic strokeNeutralization of chemokine-like factor 1, a novel C-C chemokine, protects against focal cerebral ischemia by inhibiting neutrophil infiltration via MAPK pathways in rats.Dexmedetomidine Protects Mouse Brain from Ischemia-Reperfusion Injury via Inhibiting Neuronal Autophagy through Up-Regulating HIF-1αA Reproducible and Simple Model of Permanent Cerebral Ischemia in CB-17 and SCID MiceMouse model of intraluminal MCAO: cerebral infarct evaluation by cresyl violet staining.Optimized system for cerebral perfusion monitoring in the rat stroke model of intraluminal middle cerebral artery occlusion.Are Underlying Assumptions of Current Animal Models of Human Stroke Correct: from STAIRs to High Hurdles?Role of neuronal NADPH oxidase 1 in the peri-infarct regions after stroke.The potential therapeutic effect of guanosine after cortical focal ischemia in rats.Enhancing translation: guidelines for standard pre-clinical experiments in mdx miceSex-independent neuroprotection with minocycline after experimental thromboembolic stroke.A novel mouse model of thromboembolic stroke.Long-term survival and serial assessment of stroke damage and recovery - practical and methodological considerations.Poly-arginine peptides reduce infarct volume in a permanent middle cerebral artery rat stroke modelA modification of intraluminal middle cerebral artery occlusion/reperfusion model for ischemic stroke with laser Doppler flowmetry guidance in mice.Lateral Chronic Cranial Window Preparation Enables In Vivo Observation Following Distal Middle Cerebral Artery Occlusion in Mice.Exacerbated venous thromboembolism in mice carrying a protein S K196E mutationImpact of Stroke Therapy Academic Industry Roundtable (STAIR) Guidelines on Peri-Anesthesia Care for Rat Models of Stroke: A Meta-Analysis Comparing the Years 2005 and 2015.Evolution of blood-brain-barrier permeability after acute ischemic strokeBrain protection from stroke with intravenous TNFα decoy receptor-Trojan horse fusion proteinReduced infarct size in neuroglobin-null mice after experimental stroke in vivo.Prospects for engineering neurons from local neocortical cell populations as cell-mediated therapy for neurological disordersSuccessfully Climbing the "STAIRs": Surmounting Failed Translation of Experimental Ischemic Stroke Treatments.Vitamin E prevents the age-dependent and palmitate-induced disturbances of sphingolipid turnover in liver cellsNeuroprotective Properties of a Macrolide Antibiotic in a Mouse Model of Middle Cerebral Artery Occlusion: Characterization of the Immunomodulatory Effects and Validation of the Efficacy of Intravenous Administration.Experimental approaches to study functional recovery following cerebral ischemia.Animal models of ischemic stroke and their application in clinical researchModeling stroke in mice - middle cerebral artery occlusion with the filament model.Sustained (S)-roscovitine delivery promotes neuroprotection associated with functional recovery and decrease in brain edema in a randomized blind focal cerebral ischemia study.Longitudinal assessment of imatinib's effect on the blood-brain barrier after ischemia/reperfusion injury with permeability MRI.In vivo MRI assessment of permanent middle cerebral artery occlusion by electrocoagulation: pitfalls of procedure.Bilateral common carotid artery occlusion as an adequate preconditioning stimulus to induce early ischemic tolerance to focal cerebral ischemia.Time course of neuroprotection induced by in vivo normobaric hyperoxia preconditioning and angiogenesis factors.Nano-particle delivery of brain derived neurotrophic factor after focal cerebral ischemia reduces tissue injury and enhances behavioral recovery.Induction of Ischemic Stroke and Ischemia-reperfusion in Mice Using the Middle Artery Occlusion Technique and Visualization of Infarct Area.
P2860
Q26765095-54BBB9C5-F5A1-4B40-AF5B-7C31E4254474Q26799846-46443364-F66F-48B0-8945-A5429424BF1BQ27323219-8E86FF00-8B82-4808-BE56-FD2D6B77F68EQ28394257-794FC407-190F-4E84-B80A-C471E46FF1BFQ28534767-6212C74D-6A62-44C2-A286-256D063AFDB5Q29248709-BE57B79E-5F43-400F-9F6A-60DF1429514BQ33841318-DDA8F56C-AD42-44C9-BB3F-8E9603C52107Q33875245-48D7E235-35C9-4C7E-B140-1ED64F5949DDQ34145202-5D96AE93-7A1D-4706-ABBE-3BC495B64AF0Q34483733-5C4EE269-DA26-40C4-AC31-10B7DEA261ADQ34601121-2555CD14-9C8E-43B6-A956-88386EA6373AQ34901610-02FCFD32-074B-49EE-81E9-B5F0C945C837Q35009071-D5D09E52-821C-4F4B-99EC-07EE111B6985Q35109170-7BEB5C69-B4D9-42C1-BF7C-26979E609554Q35583176-293C4C1F-2A87-4EDF-B04E-B2523A0EF708Q35779826-4DAC3352-2D10-4D30-8262-D1BD037B2C6CQ35781185-C080D003-5879-482C-B3F8-8B803175408FQ35797469-9CFCE68B-3839-41E2-BBC4-FA864726D80CQ36007755-ED8030F3-9545-4D06-B111-B36545BD98BEQ36192300-7B388B05-8832-4B13-9175-068E0BF3E8D5Q36242265-242B6187-47E6-49FF-99DF-F32FBCF652CDQ36253998-A390227A-4B91-40D9-99EC-127C1720EB4FQ36259741-6409F93C-6189-46E4-8786-B7C4A231019FQ36282432-9A94140F-DA08-4900-9B8A-F2659F5C5B5FQ36296365-8AF19E9C-BE54-4238-BA72-E5C56B3587CCQ36368027-8BF2DF91-C485-4A5B-A323-7ABFAD4A1052Q36509272-9D05D362-F595-43BE-8818-09935D31E666Q36530228-0FD018DD-DEED-44B6-9AA0-9421FC6DE9A4Q36927475-6F0A4649-4E17-4F57-B3FF-D6D7C7437280Q37125129-3488BEAB-F076-4C7A-90C0-0B3694C4BBE2Q37882518-459B4413-4543-4DF8-8B1E-B4F5A69B1542Q38546471-FE2D3489-8085-4938-A99F-E32C254F9367Q38588389-6D93C978-83FA-40A5-B1DA-6D2AF1AA4939Q38751348-AC042120-2855-4437-B6F6-7F18E85649EEQ39141643-7A61C921-36F4-4A0A-A930-95854FA20BBCQ39229352-74A83613-E5F7-4DA6-996E-6E5ABB7110A2Q42150578-8BC15C0F-D930-44C1-AD2C-7A7B6B8D44F5Q42329875-6F4F23A7-7BC4-4E2A-8446-DB924D9A5B39Q42841340-BAA4D849-AC80-478D-A2FD-2E9156691530Q46418960-13ED60BF-E3E2-4CBE-B010-79DD2BDC04D8
P2860
RODENT STROKE MODEL GUIDELINES FOR PRECLINICAL STROKE TRIALS (1ST EDITION).
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
RODENT STROKE MODEL GUIDELINES FOR PRECLINICAL STROKE TRIALS (1ST EDITION).
@ast
RODENT STROKE MODEL GUIDELINES FOR PRECLINICAL STROKE TRIALS (1ST EDITION).
@en
type
label
RODENT STROKE MODEL GUIDELINES FOR PRECLINICAL STROKE TRIALS (1ST EDITION).
@ast
RODENT STROKE MODEL GUIDELINES FOR PRECLINICAL STROKE TRIALS (1ST EDITION).
@en
prefLabel
RODENT STROKE MODEL GUIDELINES FOR PRECLINICAL STROKE TRIALS (1ST EDITION).
@ast
RODENT STROKE MODEL GUIDELINES FOR PRECLINICAL STROKE TRIALS (1ST EDITION).
@en
P2093
P2860
P356
P1476
RODENT STROKE MODEL GUIDELINES FOR PRECLINICAL STROKE TRIALS (1ST EDITION).
@en
P2093
Bruno P Meloni
Gehua Zhen
H Richard Winn
Kym Campbell
Shimin Liu
P2860
P356
10.6030/1939-067X-2.2.2
P577
2009-01-01T00:00:00Z